ENTITY

Seer (SEER US)

13
Analysis
Health Care • United States
Seer, Inc. operates as a biotechnology company. The Company offers solutions which combines proprietary engineered nanoparticles with an automated assay solution to provide an unmatched combination of unbiased, deep, rapid, and scalable workflow to give you a clearer view of the proteome. Seer serves customers in the United States.
more
Exchange Announcement • 19 Sep 2026 04:06

Current Report (Form 8-K | Period ending 2026-09-14)

Exchange Announcement • 12 Aug 2026 04:23

Current Report (Form 8-K | Period ending 2026-08-11)

Exchange Announcement • 11 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 01 Aug 2026 04:35

Current Report (Form 8-K | Period ending 2026-07-28)

Exchange Announcement • 31 Jul 2026 19:47

Current Report (Form 8-K | Period ending 2026-07-28)

x